domperidone has been researched along with morphine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (23.81) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Lefebvre, RA; Willems, JL | 1 |
| Layden, MP; Millard, WJ; Romano, TM; Simpkins, JW; Singh, M | 1 |
| Lencz, L | 1 |
| Banerjee, AK; Dhasmana, KM; Erdmann, W; Parmar, SS; Salzman, SK; Zhu, YN | 1 |
| Blancquaert, JP; Lefebvre, RA; Willems, JL | 1 |
| Drago, F; Scapagnini, U | 1 |
| Badger, TM; Friesen, HG; Martin, JB; Millard, WJ; Owens, RE; Sagar, SM; Simpkins, JW | 1 |
| Farzin, D | 1 |
| Dkhar, SA; Shashindran, CH; Shewade, DG; Suchitra, AD | 1 |
| Dkhar, SA; Krishna, PR; Ramaswamy, S; Sandhiya, S | 1 |
| Mok, SY; Ogawa, S; Parhar, IS; Tang, PY; Thiagarajan, SK | 1 |
1 trial(s) available for domperidone and morphine
| Article | Year |
|---|---|
Role of domperidone in improving intestinal activity in acute myocardial infarction patients.
Topics: Adult; Aged; Aged, 80 and over; Domperidone; Female; Gastrointestinal Motility; Humans; Intestinal Diseases; Intestinal Pseudo-Obstruction; Male; Middle Aged; Morphine; Myocardial Infarction | 1991 |
20 other study(ies) available for domperidone and morphine
| Article | Year |
|---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Gastric relaxation by morphine, apomorphine and fentanyl in the conscious dog.
Topics: Animals; Apomorphine; Benzimidazoles; Dogs; Domperidone; Fentanyl; Haloperidol; Morphine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Naloxone; Piperidines; Stomach; Vomiting | 1979 |
Opiate stimulation of prolactin secretion is reversed by ovarian hormone treatment.
Topics: Animals; Domperidone; Estradiol; Female; Luteinizing Hormone; Morphine; Pituitary Gland, Anterior; Progesterone; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Time Factors | 1992 |
Role of dopamine receptors in gastrointestinal motility.
Topics: Animals; Apomorphine; Benzazepines; Domperidone; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Gastrointestinal Motility; Gastrointestinal Transit; Haloperidol; In Vitro Techniques; Male; Morphine; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1989 |
Influence of peripheral and central administration of apomorphine and morphine on intragastric pressure in the dog.
Topics: Animals; Apomorphine; Brain; Chemoreceptor Cells; Dogs; Domperidone; Female; Injections, Intravenous; Injections, Intraventricular; Morphine; Naloxone; Pressure; Stomach; Vomiting | 1985 |
Effects of endogenous hyperprolactinaemia on opiate-induced behavioral changes in rats.
Topics: Analgesia; Animals; Behavior, Animal; Domperidone; Drug Tolerance; Heroin; Male; Morphine; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Self Administration; Transplantation, Homologous | 1985 |
Cysteamine induces depletion of both immunological and biological prolactin activity in the anterior pituitary and blood of the rat.
Topics: Animals; Cysteamine; Domperidone; Dose-Response Relationship, Drug; Male; Morphine; Pituitary Gland, Anterior; Prolactin; Radioimmunoassay; Rats; Receptors, Dopamine | 1983 |
Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Dextromethorphan; Domperidone; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Grooming; Male; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Pain; Substance Withdrawal Syndrome; Sulpiride | 1999 |
Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice.
Topics: Animals; Benzamides; Cisapride; Domperidone; Drug Interactions; Erythromycin; Female; Gastric Emptying; Gastrointestinal Transit; Male; Metoclopramide; Mice; Morphine; Morpholines | 2003 |
Role of ion channel modifiers in reversal of morphine-induced gastrointestinal inertia by prokinetic agents in mice.
Topics: Analgesics, Opioid; Animals; Benzamides; Calcium Channels; Domperidone; Gastrointestinal Tract; Glyburide; Intestine, Small; Ion Channels; Kinetics; Mice; Minoxidil; Morphine; Morpholines; Nifedipine; Time Factors | 2008 |
Integrative Roles of Dopamine Pathway and Calcium Channels Reveal a Link between Schizophrenia and Opioid Use Disorder.
Topics: Animals; Calcium Channels; Domperidone; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Locomotion; Metabolic Networks and Pathways; Morphine; Opioid-Related Disorders; Schizophrenia; Zebrafish | 2023 |